Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Teaching doctors to talk about pain: a new approach to safer opioid prescribing

NCT ID NCT03629197

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether a communication training program for primary care doctors can improve how they discuss pain with patients and manage opioid prescriptions. Doctors are randomly assigned to receive the training or standard guidelines. Researchers then record patient visits and track pain interference and prescribing patterns. The goal is to see if better communication leads to safer opioid use and better pain control.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a clinician communication skills training program using standardized patients
What this could lead to
If effective, this training could improve how doctors talk about pain and reduce risky opioid prescribing in primary care.
What could go wrong
This is a small pilot study, so results may not apply broadly. The training may not change prescribing habits or patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

95 people

The number who actually took part.

Started

Aug 2018

Finished

Dec 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Internal Medicine or Family Medicine residents at UC Davis: * completed ≥1 year of training * see primary care patients in the Ambulatory Care Center (ACC) building. Clinicians will be recruited through clinic huddles, emails, and presentations at meetings. UC Davis Patients: * 18-80 years old * taking opioids (≥1 opioid dose per day) prescribed by their primary care physician for \>90 days to treat chronic musculoskeletal pain * have an appointment scheduled with a participating clinician at which they report they are likely to discuss pain management Exclusion Criteria: * active cancer * hospice * do not speak English * prisoners * pregnant women * unable to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Communication research are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California Davis Family Medicine Clinic

    Sacramento, California, 95817, United States

  • University of California Davis Internal Medicine Clinic

    Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.